Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Primary Objective. To evaluate the effects of renin-angiotensin system (RAS) inhibitors in the treatment of adult patients with COVID-19 on total serious adverse events (TSAEs) at any stage of the illness. Secondary Objectives. To evaluate the effects of RAS inhibitors in the treatment of adult patients with COVID-19 on hospitalization duration and invasive mechanical ventilation duration.
CITATION STYLE
Smith, M., Dai, Q., Ben-Eltriki, M., & Wright, J. M. (2021). Renin-angiotensin system inhibitors for treating COVID-19 in adults. Cochrane Database of Systematic Reviews, 2020(12). https://doi.org/10.1002/14651858.CD013831
Mendeley helps you to discover research relevant for your work.